Press Room > March 2007 Archives

« February 2007 | Main | April 2007 »

Curecumin - potential treatment for lung cancer

Pharmaceutical News  Published: Wednesday, 28-Mar-2007News-Med Logo
 
Bioponic Phytoceuticals has announced that its Curecumin (a Bioresonant Phytotherapeutic form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.
 
In a recent study published in Science Direct, "Induction of Apoptosis in Human Lung Cancer Cells by Curcumin," conducted at the Department of Medicine, Pediatrics and Family and Preventive Medicine, School of Medicine, University of California, San Diego, scientists concluded, "Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has anti-inflammatory, antioxidant and anti-cancer activities... This study investigated the cellular and molecular changes induced by curcumin leading to the induction of apoptosis in human lung cancer cell lines -- A549 and H1299... Curcumin inhibited the growth of both the cell lines in a concentration dependent manner... Curcumin induced apoptosis in both the lung cancer cell lines."

Continue reading "Curecumin - potential treatment for lung cancer" »

Curecumin(TM) May Be an Effective Treatment for Lung Cancer

MAUI, Hawaii, March 27 /PRNewswire-FirstCall/ --Flask Curecumin

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin in a liquid nasal delivery system) may be an important treatment for Lung Cancer.

In a recent study published in Science Direct, "Induction of Apoptosis in Human Lung Cancer Cells by Curcumin," conducted at the Department of Medicine, Pediatrics and Family and Preventive Medicine, School of Medicine, University of California, San Diego, scientists concluded, "Curcumin, a phenolic compound from the rhizome of the plant Curcuma longa has anti-inflammatory, antioxidant and anti-cancer activities... This study investigated the cellular and molecular changes induced by curcumin leading to the induction of apoptosis in human lung cancer cell lines -- A549 and H1299... Curcumin inhibited the growth of both the cell lines in a concentration dependent manner... Curcumin induced apoptosis in both the lung cancer cell lines."

Continue reading "Curecumin(TM) May Be an Effective Treatment for Lung Cancer" »

Curecumin: possible role in prostate cancer

 "RE: Attack the stem cell CURCUMIN &P-53" DCA Discussion Forum In response to message #1
 DCA Logo
Amazing , but not surprising news on curcumin!!!!!!!!!!

Curecumin: possible role in prostate cancer
Marketletter - Mar. 26, 2007
Curecumin
Hawaii, USA-based Bioponic Phytoceuticals says that Curecumin, its bioresonant phytotherapeutic formulation of curcumin, may be an important treatment for prostate cancer.

According to the firm, curcumin, which is a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis and Alzheimer's disease. While the molecular mechanism for its anticancer effect is largely unknown, it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression, said Bioponic.

In the March 1 issue of Cancer Research, researchers from the University of Alabama reported results for curcumin in a preclinical prostate cancer model. They found that the agent decreased mRNA and protein expression of the MDM2 oncoprotein and enhanced the expression of tumor modulator p21, pointing to a potential role for Curcumin in prostate cancer, a condition which affects an estimated one in six Americans.

"We are particularly interested in the potential of our Curecumin product to provide a viable treatment strategy for those with prostate cancer. If proven effective, we may have an efficacious, cost effective, natural treatment for prostate cancer sufferers," said Steven Schorr, chief executive of Bioponic Phytoceuticals.

CureCumin™ against Prostate Cancer

By Gloria Gamat | Related entries in on prostate cancer, on anti-cancer ingredientsCancer Commentary

There has been a buzz on the anti-cancer properties of curcumin- a substance extracted from turmeric root.

Now, Curecumin™ - a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin and a product of Bioponic Phytoceuticals, Inc. (OTC: BPYT) – could be an important treatment for prostate cancer.

At least based on scientific articles posted at UroToday and published at Cancer Research.

According to Steven M. Schorr, Chairman & CEO of Bioponic Phytoceuticals, Inc.:

“We are particularly interested in the potential of our Curecumin™ product to provide a viable treatment strategy for those with prostate cancer. If proven effective, we may have an efficacious, cost effective, natural treatment for prostate cancer sufferers.”

Curecumin: possible role in prostate cancer

Threapeutics Daily News Article Marketletter Mar. 26, 2007

TD logoHawaii, USA-based Bioponic Phytoceuticals says that Curecumin, its bioresonant phytotherapeutic formulation of curcumin, may be an important treatment for prostate cancer.

According to the firm, curcumin, which is a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis and Alzheimer's disease. While the molecular mechanism for its anticancer effect is largely unknown, it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression, said Bioponic.
 

Continue reading "Curecumin: possible role in prostate cancer" »

CureCumin™ against Prostate Cancer

Buzz Tracker Logo

Cancer Commentary / Gloria Gamat March 20, 2007 

There has been a buzz on the anti-cancer properties of curcumin- a substance extracted from turmeric root.

Now, Curecumin™ - a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin and a product of Bioponic Phytoceuticals, Inc. (OTC: BPYT) – could be an important treatment for prostate cancer.
At least based on scientific articles posted at UroToday and published [...]

Curecumin May Be an Effective Treatment for Prostate Cancer

Cancer focus logo

Submitted by michael on Wed, 2007-03-21 00:40. for Cancer Foc.us

"Curcumin, a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis, and Alzheimer's disease," according to a 3/7/2007 article posted on UroToday.com. "The molecular mechanism for its anticancer effect is largely unknown, although it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression. In the March 1 issue of Cancer Research, Li and colleagues from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model." "Curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21." "This well-performed study provides an elegant mechanistic explanation for the anticancer effect of curcumin."

Continue reading "Curecumin May Be an Effective Treatment for Prostate Cancer" »

Turmeric Root Extract May Treat and Prevent Prostate Cancer

Gen logoMar 19 2007, 12:25 PM EST GEN News Highlights

Bioponic Phytoceuticals reported that Curecumin™, a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin, may be an important treatment for prostate cancer.

In the March 1 issue of Cancer Research, scientists from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model. Curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21.

Curecumin™ May Be An Effective Treatment For Prostate Cancer

Curecumin bottle

 MAUI, HAWAII, Date: March 19, 2007/ PRNewswire-

Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin™ (a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin), may be an important treatment for Prostate Cancer.

“Curcumin, a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis, and Alzheimer's disease” according to a 3/7/2007 article posted on UroToday.com, “The molecular mechanism for its anticancer effect is largely unknown, although it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression. In the March 1 issue of Cancer Research, Li and colleagues from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model.”  “curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21.” “This well-performed study provides an elegant mechanistic explanation for the anticancer effect of curcumin.”

Continue reading "Curecumin™ May Be An Effective Treatment For Prostate Cancer" »

Bioponic Phytoceuticals Announces the Addition of Dr. Richard Alpert to the Board of Directors

Dr. Richard AlpertKula, Maui, Hawaii, March 6 /PRNewswire-FirstCall/ 


Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT) today announced that Dr. Richard Alpert, author, teacher and social visionary has joined the Company's Board of Directors. Dr. Alpert (aka Ram Dass) is a world-renowned leader in the human consciousness movement. His writings have reached millions. Born in 1931, he received a Ph.D. from Stanford University where he served on the psychology faculty (and at the University of California). From 1958 to 1963 he taught in the Department of Social Relations and the Graduate School of Education at Harvard University.

"I am delighted that someone with Dr. Alpert's wealth of experience in the Complementary Alternative Medicinal field has agreed to join the Board. He brings tremendous insight and credibility to the Company," said Steven M. Schorr, Chairman & CEO -- Bioponic Phytoceuticals, Inc.

Continue reading "Bioponic Phytoceuticals Announces the Addition of Dr. Richard Alpert to the Board of Directors" »

Richard Alpert joins board of Bioponic Phytoceuticals

Posted at 9:46 a.m., Tuesday, March 6, 2007

Hon Ad logoAdvertiser Staff

Bioponic Phytoceuticals Inc., a Kula, Maui-based developer of products for sale in the complementary alternative medicine and natural products markets, said Richard Alpert has joined its board of directors.Dr. Richard Alpert
Alpert, also known as Ram Dass, is well known for writing and co-writing books that include Be Here Now and Journey of Awakening. Alpert is a Maui resident who holds a doctorate at Stanford University, where he also served on the psychology faculty. He also taught at the University of California and at Harvard University, Bioponic Phytoceuticals said in a news release.